Differential Effects of Prevention and Reversal Treatment with Lisinopril on Left Ventricular Remodelling in a Rat Model of Heart Failure

Heart Lung and Circulation

Volumn 24, Issue 9, 2015, Pages 919-924

  Brower, Gregory L ^a   Levick, Scott P ^b   Janicki, Joseph S ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Angiotensin converting enzyme inhibitor; Heart failure; Hypertrophy; Volume overload

Indexed keywords

LISINOPRIL;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTOCAVAL FISTULA; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE OVERLOAD; HEART LEFT VENTRICLE SIZE; HEART MUSCLE COMPLIANCE; HEART MUSCLE CONTRACTILITY; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT DURATION; ANIMAL; CARDIOMEGALY; DISEASE MODEL; DRUG EFFECTS; HEART CONTRACTION; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CARDIOMEGALY; DISEASE MODELS, ANIMAL; HEART FAILURE; LISINOPRIL; MALE; MYOCARDIAL CONTRACTION; RATS; RATS, SPRAGUE-DAWLEY; VENTRICULAR REMODELING;

EID: 84940790813     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2015.02.023     Document Type: Article

References (23)

1. HFSA Heart Failure Society of America (HFSA) practice guidelines. J Cardiac Fail 1999, 5:357-382.
2. Konstam M.A., Rousseau M.F., Kronenberg M.W., Udelson J.E., Melin J., Stewart D., et al. Effects of angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD investigators. Circ 1992, 86:431-438.
3. Pfeffer M.A., Braunwald E., Moye L.A., Basta L., Brown E.J., Cuddy T.E., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE investigators. N Eng J Med 1992, 327:669-677.
4. Brower G.L., Levick S.P., Janicki J.S. Inhibition of matrix metalloproteinase activity by ACE inhibitors prevents left ventricular remodeling in a rat model of heart failure. Am J Physiol Heart Circ Physiol 2007, 292:H3057-H3064.
5. Brower G.L., Henegar J.R., Janicki J.S. Temporal evaluation of left ventricular remodeling and function in rats with chronic volume overload. Am J Physiol 1996, 271:H2071-H2078.
6. Brower G.L., Janicki J.S. Pharmacologic inhibition of mast cell degranulation prevents left ventricular remodeling induced by chronic volume overload in rats. J Cardiac Fail 2005, 11:548-556.
7. Chancey A.L., Brower G.L., Janicki J.S. Cardiac mast cell-mediated activation of gelatinase and alteration of ventricular diastolic function. Am J Physiol 2002, 282:H2152-H2158.
8. Chancey A.L., Brower G.L., Peterson J.T., Janicki J.S. Effects of matrix metalloproteinase inhibition on ventricular remodeling due to volume overload. Circ 2002, 105:1983-1988.
9. Jobe L.J., Melendez G.C., Levick S.P., Du Y., Brower G.L., Janicki J.S. TNF-α inhibition attenuates adverse myocardial remodeling in a rat model of volume overload. Am J Physiol Heart Circ Physiol 2009, 297:H1462-H1468.
10. Melendez G.C., McLarty J.L., Levick S.P., Du Y., Janicki J.S., Brower G.L. Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats. Hypertension 2010, 56:225-231.
11. Sakata Y., Yamamoto K., Mano T., Nishikawa N., Yoshida J., Hori M., et al. Activation of matrix metalloproteinases precedes left ventricular remodeling in hypertensive heart failure rats: its inhibition as a primary effect of angiotensin-converting enzyme inhibitor. Circ 2004, 109:2143-2149.
12. Ruzicka M., Skarda V., Leenen F.H. Effects of ACE inhibitors on circulating versus cardiac angiotensin II in volume overload induced cardiac hypertrophy in rats. Circ 1995, 92:3568-3573.
13. McElmurray J.H., Mukherjee R., New R.B., Sampson A.C., King M.K., Hendrick J.W., et al. Angiotensin-converting enzyme and matrix metalloproteinase inhibition with developing heart failure: comparative effects on left ventricular function and geometry. JPET 1999, 291:799-811.
14. Spinale F.G., de Gasparo M., Whitebread S., Hebbar L., Clair M.J., Melton D.M., et al. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure. Circ 1997, 96:2385-2396.
15. Stewart J.A., Gardner J.D., Brower G.L., Janicki J.S. Temporal changes in integrin-mediated cardiomyocyte adhesion secondary to chronic cardiac volume overload in rats. Am. J. Physiol Heart Circ. Physiol 2014, 306:H101-H108.
16. Burgess M.L., Carver W.E., Terracio L., Wilson S.P., Wilson M.A., Borg T.K. Integrin-mediated collagen gel contraction by cardiac fibroblasts. Effects of angiotensin II. Circ Res 1994, 74:291-298.
17. Kryczka J., Stasiak M., Dziki L., Mik M., Dziki A., Cierniewski C. Matrix metalloproteinase-2 cleavage of the beta1 integrin ectodomain facilitates colon cancer cell motility. J. Biol. Chem. 2012, 287:36556-36566.
18. Gerdes A.M. Cardiac myocyte remodeling in hypertrophy and progression to failure. J Card Fail 2002, 8:S264-S268.
19. Linke W.A., Popov V.I., Pollack G.H. Passive and active tension in single cardiac myofibrils. Biophysical J. 1994, 67:782-792.
20. Makarenko I., Opitz C.A., Leake M.C., Neagoe C., Kulke M., Gwathmey J.K., et al. Passive stiffness changes caused by upregulation of compliant titan isoforms in human dilated cardiomyopathy hearts. Circ Res 2004, 95:708-716.
21. Neagoe C., Kulke M., del Monte F., Gwathmey J.K., de Tombe P.P., Hajjar R.J., et al. Titin isoform switch in ischemic human heart disease. Circ 2002, 106:1333-1341.
22. Du Y., Plante E., Janicki J.S., Brower G.L. Temporal evaluation of cardiac myocyte hypertrophy and hyperplasia in male rats secondary to chronic volume overload. Am. J. Pathol. 2010, 177:1155-1163.
23. Ruzicka M., Yuan B., Leenen F.H. Effects of enalapril versus losartan on regression of volume overload-induced cardiac hypertrophy in rats. Circ 1994, 90:484-491.